Sale of 4,015 shares at $40 per share.
Reporting Person Leite John · Officer Title Global Chief Commercial Off · Transaction Code S
Traded Sep 21, 2026 · Disclosed Sep 22, 2026
Source: SEC Form 4 · 0001991536-26-000013 · filed 2026-09-22 · View filing →
Sale of 5,000 shares at $40.9494 per share.
Reporting Person Holstein Jens · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001819880-26-000004 · filed 2026-09-16 · View filing →
Sale of 10,405 shares at $42.8933 per share.
Reporting Person Febbo Phillip G. · Officer Title Chief Scientific & Med Officer · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001649245-26-000009 · filed 2026-09-04 · View filing →
Sale of 2,705 shares at $43.6618 per share.
Reporting Person Febbo Phillip G. · Officer Title Chief Scientific & Med Officer · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001649245-26-000009 · filed 2026-09-04 · View filing →
Sale of 2,477 shares at $42.8059 per share.
Reporting Person Chambers Rebecca · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001823563-26-000016 · filed 2026-09-04 · View filing →
Sale of 1,175 shares at $43.714 per share.
Reporting Person Chambers Rebecca · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001823563-26-000016 · filed 2026-09-04 · View filing →
Sale of 2,154 shares at $42.7916 per share.
Reporting Person McGuire Annie · Officer Title EVP, General Counsel · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001914620-26-000013 · filed 2026-09-04 · View filing →
Sale of 1,100 shares at $43.6718 per share.
Reporting Person McGuire Annie · Officer Title EVP, General Counsel · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001914620-26-000013 · filed 2026-09-04 · View filing →
Disposition (code F) of 8,782 shares at $44.88 per share.
Reporting Person Stapley Marc · Officer Title Chief Executive Officer · Transaction Code F
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001539796-26-000019 · filed 2026-09-04 · View filing →
Disposition (code F) of 1,361 shares at $44.88 per share.
Reporting Person Wygant Jonathan · Officer Title VP, Chief Accounting Officer · Transaction Code F
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001584145-26-000009 · filed 2026-09-04 · View filing →
Disposition (code F) of 3,639 shares at $44.88 per share.
Reporting Person Febbo Phillip G. · Officer Title Chief Scientific & Med Officer · Transaction Code F
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001649245-26-000009 · filed 2026-09-04 · View filing →
Disposition (code F) of 3,603 shares at $44.88 per share.
Reporting Person Chambers Rebecca · Officer Title Chief Financial Officer · Transaction Code F
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001823563-26-000016 · filed 2026-09-04 · View filing →
Disposition (code F) of 3,215 shares at $44.88 per share.
Reporting Person McGuire Annie · Officer Title EVP, General Counsel · Transaction Code F
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001914620-26-000013 · filed 2026-09-04 · View filing →
Disposition (code F) of 3,961 shares at $44.88 per share.
Reporting Person Leite John · Officer Title Global Chief Commercial Off · Transaction Code F
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001991536-26-000011 · filed 2026-09-04 · View filing →
Sale of 1,864 shares at $42.97 per share.
Reporting Person Bhanji Muna · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001846905-26-000006 · filed 2026-09-03 · View filing →